Pathogenesis of Crohn's disease and ulcerative colitis;Pathophysiologie der Chronisch entzündlichen darmkrankheiten

Therapeutische Umschau

Volumn 60, Issue 3, 2003, Pages 127-132

  Lehmann, F S ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYTOKINE;

ARTICLE; CHRONIC INFLAMMATION; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE COURSE; ENTERITIS; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INTESTINE FLORA; MEDIATOR RELEASE; MYCOBACTERIUM; NUTRITION; PATHOPHYSIOLOGY; PHENOTYPE; SMOKING; ULCERATIVE COLITIS;

EID: 0037230414     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.60.3.127     Document Type: Article

References (33)

1. Kirsner J, Spencer J. Familial occurences of ulcerative colitis, regional enteritis and ileocolitis. Ann Intern Med 1963; 59: 133-44.
2. Sandler R. Epidemiology of inflammatory bowel disease. In: Targan S, Shanhan F eds. Inflammatory Bowel Disease: from Bench to Bedside. Baltimore: Williams & Wilkins, 1994; 5-30.
3. Roth MP, Petersen GM, McElree C, Feldman E, Rotter JI. Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology 1989; 97: 900-4.
4. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988; 29: 990-6.
5. Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP. Review article: the genetics of inflammatory bowel disease. Aliment Pharmacol Ther 2001; 15: 731-48.
6. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821-3.
7. Curran ME, Lau KF, Hampe J, Schreiber S, Bridger S, Macpherson AJ et al. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkeage to chromosomes 12 and 16. Gastroenterology 1998; 115: 1066-71.
8. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996; 14: 199-202.
9. Bayless TM, Tokayer AZ, Polito JM, Quaskey SA, Mellits ED, Harris ML. Crohn's disease; concordance for site and clinical type in affected family members-potential hereditary influences. Gastroenterology 1996; 111: 573-9.
10. Hubbard J, Surawicz CM. Etiological role of mycobacterium in Crohn's disease: An assessment of the literature. Dig Dis 1999; 17: 6-13.
11. Wakefield AJ, Ekbom A, Dhillon AP, Pitillo RM, Pounder RE. Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 1995; 108: 911-6.
12. Lewin J, Dhillon AP, Sim R, Mazure G, Pounder RE, Wakefield AJ. Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy. Gut 1995;36:564-9.
13. Knoflach P, Park BH, Cunningham R, Weisser MM, Albini B. Serum antibodies to cow's milk proteins in ulcerative colitis and Crohn's disease. Gastroenterology 1987; 92: 479-85.
14. Roozendaal C, Pogany K, Hummel EJ, Horst G, Dijkstra G, Nelis GF et al. Titres of anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease are not related to disease activity. QJM 1999; 92: 651-8.
15. Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, et al. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 1995; 108: 21-33.
16. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157: 1261-70.
17. Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT. Tumor necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992; 339: 89-91.
18. Stallmach A, Schafer F, Hoffmann S, Weber S, Muller-Molaian I, Schneider T, et al. Increased state of activation of CD4 positive T cells and elevated interferon gamma production in pouchitis. Gut 1998; 43: 499-505.
19. Mahida YR, Lamming CE, Gallagher A, Hawthorne AB, Hawkey CJ. 5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsies from patients with inflammatory bowel disease. Gut 1991; 32: 50-4.
20. Isaacs KL, Sartor RB, Haskill JS. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992; 103: 1587-95.
21. Sher ME, D'Angelo AJ, Stein TA, Bailey B, Burns G, Wise L. Cytokines in Crohn's colitis. Am J Surg 1995; 169: 133-6.
22. Nielsen OH, Koppen T, Rudiger N, Horn T, Eriksen J, Kirman I. Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig Dis Sci 1996; 41: 1786-93.
23. Hyams JS, Fitzgerald JE, Treem WR, Wyzga N, Kreutzer DL. Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease. Gastroenterology 1993; 104: 1285-92.
24. Raab Y, Hallgren R, Gerdin B. Enhanced intestinal synthesis of interleukin-6 is related to the disease severity and activity in ulcerative colitis. Digestion 1994; 55: 44-49.
25. Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue JA et al. Expression of interleukin-8 in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 1994; 144: 997-1007.
26. Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997; 112: 1169-78.
27. Sobhani I, Hochlaf S, Denizot Y, Vissuzaine C, Rene E, Bonveniste J et al. Raised concentration of platelet activating factor in colonic mucosa of Crohn's disease patients. Gut 1992; 33: 1220-5.
28. Yang VW. Eicosanoids and inflammatory bowel disease. Gastroenterol Clin North Am 1996; 25: 317-32.
29. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994; 344: 859-61.
30. Boughton-Smith NK, Evans SM, Hawkey CJ, Cole AT, Balsitis M, Whittle BJ et al. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993; 342: 338-40.
31. Harries AD, Baird A, Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) 1982; 284: 706.
32. Somerville KW, Logan RF, Edmond M, Langman MJ. Smoking and Crohn's disease. Br Med J (Clin Res Ed) 1984; 289: 954-6.
33. Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995; 37: 668-73.